0001209191-21-021581.txt : 20210317
0001209191-21-021581.hdr.sgml : 20210317
20210317200034
ACCESSION NUMBER: 0001209191-21-021581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210317
DATE AS OF CHANGE: 20210317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: James Steven P
CENTRAL INDEX KEY: 0001243025
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38582
FILM NUMBER: 21752511
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPUETICS
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER NAME:
FORMER CONFORMED NAME: JAMES STEVEN P
DATE OF NAME CHANGE: 20030617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allakos Inc.
CENTRAL INDEX KEY: 0001564824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454798831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 975 ISLAND DRIVE
STREET 2: SUITE 201
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-597-5002
MAIL ADDRESS:
STREET 1: 975 ISLAND DRIVE
STREET 2: SUITE 201
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-16
0
0001564824
Allakos Inc.
ALLK
0001243025
James Steven P
C/O ALLAKOS INC.
975 ISLAND DRIVE, SUITE 201
REDWOOD CITY
CA
94065
1
0
0
0
Common Stock
2021-03-16
4
S
0
3500
121.65
D
0
D
Common Stock
2021-03-16
4
M
0
3500
0.525
A
3500
D
Stock Option (Right to buy)
0.525
2021-03-16
4
M
0
3500
0.00
D
2026-04-28
Common Stock
3500
59380
D
This transaction was executed in multiple trades at prices ranging from $121.50 to $121.70 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
On April 28, 2016, the Reporting Person was granted an option to purchase 62,880 ordinary shares pursuant to the Company's 2012 Equity Incentive Plan. The option vests as to one forty-eight of the shares on May 28, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
/s/ Jeff Macfarland, by power of attorney
2021-03-17